These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Chemotherapy of neoplasms in oncological departments]. Zelechowska JA Pol Tyg Lek; 1969 Dec; 24(50):1942-3. PubMed ID: 4904422 [No Abstract] [Full Text] [Related]
45. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXXII. Plant extracts. Abbott BJ; Leiter J; Hartwell JL; Perdue RE; Schepartz SA Cancer Res; 1966 Apr; 26(4 Pt 2):391-569. PubMed ID: 5940852 [No Abstract] [Full Text] [Related]
46. Cancer chemotherapy: a guide for nurses. Thomson L Nurs Times; 1979 Nov; 75(47):suppl: 17-20. PubMed ID: 260056 [No Abstract] [Full Text] [Related]
47. Current status of cancer chemotherapy. Henderson IW Can Nurse; 1967 Apr; 63(4):37-40. PubMed ID: 6019255 [No Abstract] [Full Text] [Related]
48. [Present-day chemotherapy of cancer]. Nichol CA Laval Med; 1968 Oct; 39(8):670-2. PubMed ID: 5748232 [No Abstract] [Full Text] [Related]
49. Drugs of choice for cancer chemotherapy. Med Lett Drugs Ther; 1995 Mar; 37(945):25-32. PubMed ID: 7898397 [No Abstract] [Full Text] [Related]
50. Chemotherapy in the treatment of ovarian cancer. Limburg HG Proc R Soc Med; 1969 Apr; 62(4):361-2. PubMed ID: 4980488 [No Abstract] [Full Text] [Related]
51. Drugs of choice for cancer chemotherapy. Conn Med; 2000 Oct; 64(10):613-24. PubMed ID: 11100633 [No Abstract] [Full Text] [Related]
52. [Chemotherapy of advanced cancer]. Cerný V Cas Lek Cesk; 1972 Nov; 111(45):1066-7. PubMed ID: 5084861 [No Abstract] [Full Text] [Related]
53. Suspension culture combined with anticancer regimens for screening breast cancer stem cells. Li HZ; Yi TB; Wu ZY Med Hypotheses; 2007; 68(5):988-90. PubMed ID: 17125933 [TBL] [Abstract][Full Text] [Related]
54. Present status of clinical cancer chemotherapy. Ansfield FJ Antimicrob Agents Chemother (Bethesda); 1965; 5():1096-101. PubMed ID: 5883406 [No Abstract] [Full Text] [Related]
55. Qualitative and quantitative in vitro sensitivity tests for cancer chemotherapy. Knock FE Natl Cancer Inst Monogr; 1971 Dec; 34():247-50. PubMed ID: 5140870 [No Abstract] [Full Text] [Related]
56. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy. Ledzewicz U; Schättler H Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967 [TBL] [Abstract][Full Text] [Related]
57. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXXI. Plant extracts. Abbott BJ; Leiter J; Hartwell JL; Price JR; Perdue RE; Schepartz SA Cancer Res; 1966 Mar; 26(3 Pt 2):207-373. PubMed ID: 5212552 [No Abstract] [Full Text] [Related]
58. Induction chemotherapy: to downgrade aggressive cancers to improve curability by surgery and/or radiotherapy. Stephens FO Eur J Surg Oncol; 2001 Nov; 27(7):672-88. PubMed ID: 11669597 [TBL] [Abstract][Full Text] [Related]
59. 3-D culture in synthetic extracellular matrices: new tissue models for drug toxicology and cancer drug discovery. Prestwich GD; Liu Y; Yu B; Shu XZ; Scott A Adv Enzyme Regul; 2007; 47():196-207. PubMed ID: 17335875 [No Abstract] [Full Text] [Related]
60. [Symposium on the chemotherapy of cancer. Address of the president of the conference]. Cantero A Laval Med; 1968 Oct; 39(8):667-9. PubMed ID: 5748231 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]